These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 17400510)

  • 1. Mesenchymal stem cells: a new strategy for immunosuppression?
    Uccelli A; Pistoia V; Moretta L
    Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
    Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
    Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
    Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
    Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
    Le Blanc K; Ringdén O
    Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune plasticity of bone marrow-derived mesenchymal stromal cells.
    Stagg J; Galipeau J
    Handb Exp Pharmacol; 2007; (180):45-66. PubMed ID: 17554504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation by mesenchymal stem cells and clinical experience.
    Le Blanc K; Ringdén O
    J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of bone marrow-derived mesenchymal stem cells in a xenotransplantation model.
    Wang Y; Chen X; Armstrong MA; Li G
    J Orthop Res; 2007 Jul; 25(7):926-32. PubMed ID: 17415789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ; McTaggart SJ
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation.
    Le Blanc K; Ringdén O
    Curr Opin Immunol; 2006 Oct; 18(5):586-91. PubMed ID: 16879957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
    Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
    Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells.
    Bernardo ME; Locatelli F; Fibbe WE
    Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune properties of mesenchymal stem cells.
    Sotiropoulou PA; Papamichail M
    Methods Mol Biol; 2007; 407():225-43. PubMed ID: 18453259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
    Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
    Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for mesenchymal stem cells in the control of graft-versus-host disease.
    Cohen JL; Sudres M
    Transplantation; 2009 May; 87(9 Suppl):S53-4. PubMed ID: 19424007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
    Kassis I; Grigoriadis N; Gowda-Kurkalli B; Mizrachi-Kol R; Ben-Hur T; Slavin S; Abramsky O; Karussis D
    Arch Neurol; 2008 Jun; 65(6):753-61. PubMed ID: 18541795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
    Müller I; Lymperi S; Dazzi F
    Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation?
    Mishra PK
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):122-8. PubMed ID: 18192802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
    Poncelet AJ; Vercruysse J; Saliez A; Gianello P
    Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune modulation by mesenchymal stem cells.
    Rasmusson I
    Exp Cell Res; 2006 Jul; 312(12):2169-79. PubMed ID: 16631737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells can affect solid organ allograft survival.
    Popp FC; Eggenhofer E; Renner P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
    Transplantation; 2009 May; 87(9 Suppl):S57-62. PubMed ID: 19424009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.